We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

80 hedge funds and large institutions have $47M invested in Ampio Pharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

7% more funds holding

Funds holding: 75 → 80 (+5)

53% less call options, than puts

Call options by funds: $853K | Put options by funds: $1.82M

60% less capital invested

Capital invested by funds: $116M → $47M (-$69.1M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
15
Increased
32
Reduced
13
Closed
9
Calls
$853K
Puts
$1.82M
Net Calls
-$967K
Net Calls Change
+$1.3M

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$2.28M
2
BIT
BlackRock Institutional Trust
California
+$1.49M
3
Morgan Stanley
Morgan Stanley
New York
+$1.07M
4
IMS
Index Management Solutions
Pennsylvania
+$929K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$633K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$7.02M
2
TC
Talkot Capital
California
-$3.01M
3
SFM
Sphera Funds Management
Israel
-$2.6M
4
Millennium Management
Millennium Management
New York
-$670K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$469K
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
76
Creative Planning
Kansas
$1K -$1.68K -1 -50%
LTFS
77
Ladenburg Thalmann Financial Services
Florida
$1K – – –
SM
78
Sabby Management
Florida
$497 +$524K +311 +197%
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$98 +$3.37K +2 +2%
CIA
80
Capital Impact Advisors
Massachusetts
$81 – – –
SFM
81
Sphera Funds Management
Israel
– -$2.6M -1,040 Closed
Millennium Management
82
Millennium Management
New York
– -$670K -268 Closed
AQR Capital Management
83
AQR Capital Management
Connecticut
– -$469K -187 Closed
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
– -$388K -155 Closed
GMCM
85
Gruber & McBaine Capital Management
California
– -$251K -100 Closed
GC
86
Guggenheim Capital
Illinois
– -$197K -78 Closed
DADC
87
D.A. Davidson & Co
Montana
– -$41K -17 Closed
VFA
88
Virtus Fund Advisers
Connecticut
– -$29K -12 Closed
EWM
89
Evercore Wealth Management
New York
– -$21K -8 Closed
1 2 3
4

AMPE Hedge Fund Activity: Q3 2014 in Review

80 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2014, worth a combined $47M — down 60% from $116M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AMPE positions and 9 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.

The largest buyer was Knoll Capital Management, adding an estimated $2.28M. The largest seller was DAFNA Capital Management, cutting an estimated $7.02M.

  • 80 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2014, up from 75 in Q2 2014.
  • Funds reported $47M of Ampio Pharmaceuticals Inc. stock for Q3 2014, down 60% quarter-over-quarter.
  • 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2014 and 9 closed out, a net change of +6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2014 was Knoll Capital Management, an estimated $2.28M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2014 was DAFNA Capital Management, an estimated $7.02M sold.

Based on aggregated 13F filings for Q3 2014.